Dose Escalation & Expansion Study of Oral VRx-3996 & Valganciclovir in Subjects With EBV+ Lymphoid Malignancies
Viracta Therapeutics, Inc.
Viracta Therapeutics, Inc.
Gene Surgery LLC
Abramson Cancer Center at Penn Medicine
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
AIDS Malignancy Consortium
City of Hope Medical Center
National Cancer Institute (NCI)
Huazhong University of Science and Technology
Boston Medical Center
National Cancer Institute (NCI)
University of Alabama at Birmingham
Fred Hutchinson Cancer Center